BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Mesoblast

Mesoblast logo

Founded
2004
Patents
54
Clinical Trials
32
Publications
43

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC)
technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney
disease, orthopedic spine conditions, and cardiovascular disorders.

Get access to BPT Crunch to view additional information about this company